Nuveen Asset Management, LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$606,224
-26.9%
452,406
-2.4%
0.00%
Q2 2023$829,726
+11893.7%
463,534
-73.9%
0.00%
-100.0%
Q1 2023$6,918
+27.7%
1,778,532
+11.6%
0.00%
+50.0%
Q4 2022$5,419
-99.9%
1,593,710
-19.1%
0.00%
-50.0%
Q3 2022$10,762,000
+25.9%
1,971,048
+4.0%
0.00%
+33.3%
Q2 2022$8,548,000
-28.3%
1,895,378
+4.2%
0.00%
-25.0%
Q1 2022$11,915,000
+77.4%
1,819,048
+53.6%
0.00%
+100.0%
Q4 2021$6,715,000
-1.1%
1,184,310
+5.8%
0.00%0.0%
Q3 2021$6,792,000
-42.1%
1,119,008
-1.5%
0.00%
-33.3%
Q2 2021$11,723,000
+19.9%
1,135,916
+22.2%
0.00%0.0%
Q1 2021$9,779,000
-38.5%
929,561
-9.5%
0.00%
-40.0%
Q4 2020$15,907,000
+3.5%
1,027,588
-2.3%
0.01%
-16.7%
Q3 2020$15,363,000
+91.9%
1,052,236
+148.9%
0.01%
+100.0%
Q2 2020$8,006,000
+46.6%
422,746
+48.7%
0.00%0.0%
Q1 2020$5,460,000
-38.4%
284,219
-38.5%
0.00%0.0%
Q4 2019$8,863,000
+131.2%
462,347
+16.0%
0.00%
+50.0%
Q3 2019$3,834,000
+66.0%
398,523
+3.3%
0.00%
+100.0%
Q2 2019$2,310,000
+356.5%
385,707
+3448.4%
0.00%
-66.7%
Q2 2014$506,000
+57.1%
10,870
+4.2%
0.00%
+50.0%
Q1 2014$322,000
-24.2%
10,430
-43.8%
0.00%
-33.3%
Q4 2013$425,00018,5510.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders